295 participants
COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-10-17
- Start Date:
- 2021-04-29
- Completion:
- 2022-11-21
Conditions
- Healthy
- Chronic Stable Illness
Interventions
- DRUG
- BIOLOGICAL